Metraipolis › archive › dc_2ff49fcf8ac2
Occult breast cancer showing a marked response to pembrolizumab plus gemcitabine and carboplatin therapy complicated by immune-related colitis: A case report — Europe PMC PMID:42343990
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42343990
- DOI
- 10.3892/mco.2026.2961
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T16:42:24.481Z
- SHA-256 of the archived text
a776623904f9208a7d87daf491bc6c50f5dfde963f6fce7bbbdbbe84329497db- Stable URL of this page
https://metraipolis.com/documento/dc_2ff49fcf8ac2
How to cite
Occult breast cancer showing a marked response to pembrolizumab plus gemcitabine and carboplatin therapy complicated by immune-related colitis: A case report — Europe PMC PMID:42343990 — Europe PMC (en), https://europepmc.org/article/MED/42343990 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ff49fcf8ac2 (Metraipolis archive dc_2ff49fcf8ac2, sha256 a776623904f9208a7d87daf491bc6c50f5dfde963f6fce7bbbdbbe84329497db)
BibTeX
@misc{dc2ff49fcf8ac2,
title = {Occult breast cancer showing a marked response to pembrolizumab plus gemcitabine and carboplatin therapy complicated by immune-related colitis: A case report — Europe PMC PMID:42343990},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42343990},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ff49fcf8ac2; sha256 a776623904f9208a7d87daf491bc6c50f5dfde963f6fce7bbbdbbe84329497db},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42343990. Agents can read the archived copy with the MCP tool read_document.